These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36537896)

  • 1.
    Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
    Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
    Waheed A; Dorbala S
    Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
    Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
    Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
    JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
    J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A; Mahmood U; Tang X; Jain D; Pan S
    J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
    Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
    Takahashi K; Sasaki D; Yamashita M; Sakaue T; Enomoto D; Morioka H; Uemura S; Okura T; Ikeda S; Kono T; Hiratsuka Y; Saijo A; Yamamura N; Kitazawa S; Yamashita T; Ueda M
    J Nucl Cardiol; 2022 Dec; 29(6):3126-3136. PubMed ID: 34964085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.
    Stats MA; Stone JR
    Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 19. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
    Takahashi K; Iwamura T; Hiratsuka Y; Sasaki D; Yamamura N; Ueda M; Morioka H; Yoshino M; Enomoto D; Uemura S; Okura T; Sakaue T; Ikeda S
    Intern Med; 2024 Jun; 63(11):1575-1584. PubMed ID: 37899242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.